CVS Health Co. (NYSE:CVS) Shares Sold by Vicus Capital

Vicus Capital lessened its holdings in shares of CVS Health Co. (NYSE:CVS) by 12.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,613 shares of the pharmacy operator’s stock after selling 772 shares during the quarter. Vicus Capital’s holdings in CVS Health were worth $443,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. Criterion Capital Advisors LLC acquired a new position in CVS Health during the fourth quarter worth about $75,000. Powell Investment Advisors LLC acquired a new position in shares of CVS Health during the 4th quarter worth approximately $208,000. Lindbrook Capital LLC grew its position in shares of CVS Health by 35.3% in the fourth quarter. Lindbrook Capital LLC now owns 9,013 shares of the pharmacy operator’s stock valued at $712,000 after purchasing an additional 2,351 shares in the last quarter. DT Investment Partners LLC increased its holdings in shares of CVS Health by 43.5% in the fourth quarter. DT Investment Partners LLC now owns 2,575 shares of the pharmacy operator’s stock valued at $190,000 after purchasing an additional 781 shares during the last quarter. Finally, J.W. Cole Advisors Inc. lifted its position in CVS Health by 3.1% during the fourth quarter. J.W. Cole Advisors Inc. now owns 18,267 shares of the pharmacy operator’s stock worth $1,442,000 after buying an additional 546 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Up 1.5 %

CVS Health stock traded up $1.02 during mid-day trading on Friday, hitting $69.75. The company had a trading volume of 7,809,721 shares, compared to its average volume of 8,823,763. The stock has a market cap of $87.92 billion, a price-to-earnings ratio of 10.80, a PEG ratio of 0.92 and a beta of 0.52. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. CVS Health Co. has a 1 year low of $64.41 and a 1 year high of $83.25. The business has a fifty day moving average of $75.29 and a 200 day moving average of $73.74.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The firm had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. During the same period last year, the business earned $1.99 EPS. CVS Health’s revenue for the quarter was up 11.9% compared to the same quarter last year. On average, sell-side analysts expect that CVS Health Co. will post 8.32 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be issued a $0.665 dividend. The ex-dividend date is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.81%. CVS Health’s payout ratio is 41.18%.

Insider Activity at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.24% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on CVS shares. SVB Leerink assumed coverage on shares of CVS Health in a report on Monday, February 26th. They issued an “outperform” rating and a $88.00 price objective for the company. StockNews.com downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Piper Sandler upped their price objective on CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, March 15th. Cantor Fitzgerald reissued an “overweight” rating and set a $87.00 target price on shares of CVS Health in a research note on Wednesday, April 10th. Finally, Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a research report on Monday, February 26th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $89.44.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.